The p53 tumor suppressor protein, a transcription factor, induces cell cycle arrest and apoptosis via the upregulation of downstream target genes. Ferredoxin Reductase (protein, FR; gene, FDXR) transfers electron from NADPH to cytochrome P450 via ferredoxin in mitochondria. Here, we identified FDXR as a target gene of the p53 family, that is, p53, p63, and p73. We found that FDXR can be induced by DNA damage in cells in a p53-dependent manner and by a mutated form of p53 that is competent in inducing apoptosis. In addition, we identified a p53 response element located within the FDXR promoter that is responsive to wild-type p53, p63a, p63g, p73a, and p73b. Furthermore, we showed that p53, p63a and p73a directly bind to the p53 response element in vivo and promote the accessibility of the FDXR promoter by increasing the acetylation of histones H3 and H4. To determine the role of FR in p53 tumor suppression, we generated cell lines that express FR using a tetracycline-regulated promoter. We found that overexpression of FR in lung H1299, breast MCF7, and colorectal HCT116 carcinoma cells have no effect on cell proliferation. However, we showed that FR increases the sensibility of H1299 and HCT116 cells to 5-fluorouracil-, doxorubicin-and H 2 O 2 -mediated apoptosis. Our data support a model of feed-forward loop for p53 activity, that is, various cellular stresses, including reactive oxygen species (ROS), activate p53, which induces the expression of FDXR; and the FDXR gene product, FR, in turn sensitizes cells to ROS-mediated apoptosis.
Introduction
p53 tumor suppressor gene is frequently inactivated in cancer (Hollstein et al., 1991) . p53 plays an important role in the maintenance of normal cell growth and homeostasis by regulating cell cycle arrest and apoptosis (Vogelstein et al., 2000) . In response to cellular stresses, such as DNA damage and oncogene activation, p53 is activated and induces a number of target genes. Among these are p21 (el-Deiry et al., 1993; Harper et al., 1993; Xiong et al., 1993) , which mediates cell cycle arrest in G1 and G2; 14-3-3s (Hermeking et al., 1997) and GADD45 (Wang et al., 1999) , which mediate cell cycle arrest in G2; and Bax (Miyashita and Reed, 1995) , PUMA (Nakano and Vousden, 2001; Yu et al., 2001) , and MCG10 , which mediate apoptosis.
The p53 family consists of p53, p63, and p73 (Chen, 1999; Yang and McKeon, 2000) . p73 and p63 have a high sequence identity with p53 in the activation, DNA binding, and tetramerization domains. These domains are critical for p53 activity (Ko and Prives, 1996) . Both p73 and p63 have multiple isoforms, each differing in the length of their C-termini (Kaelin, 1999; Yang and McKeon, 2000) . Several studies have shown that p73 and p63 can transactivate some p53 target genes and induce cell cycle arrest and apoptosis (Chen, 1999; Yang and McKeon, 2000) . The p63g and p73b form, which lack the sterile alpha motif (SAM) within their carboxyl terminus, are more potent in transactivation than the a forms, which contain the SAM domain. This suggests that like the carboxyl terminal basic domain of p53, the extreme C terminus may exert an autoinhibitory effect on the transcriptional activity of the alpha forms of p63 and p73 (Irwin and Kaelin, 2001; Yang et al., 2002) . TP73 and TRP63 can be transcribed from the cryptic promoter in intron 3, producing N-terminal truncations (DN) (Yang et al., 1998; Yang and McKeon, 2000) . The DN variants of p73 and p63 are thought to be transcriptionally inactive since they lack the acidic N-terminus corresponding to the N-terminal activation domain of p53. However, DNp63a is active in transactivation (Dohn, 2001a) and thus, the activity of the DN variants of p63 and p73 needs to be re-evaluated.
Reactive oxygen species (ROS), such as hydrogen peroxide and hydroxyl radical, are generated from normal metabolic processes or toxic insults. ROS are harmful to cells and can damage macromolecules, including nucleic acids and proteins (Chandra et al., 2000) . There is growing evidence that ROS play a role in the induction of apoptosis. ROS production is a critical process of toxicity associated with exposure to ionizing radiation and chemotherapeutic drugs (Allen and Tresini, 2000) . But how ROS induce apoptosis is not well understood. Since ROS are mainly produced in mitochondria, ROS may oxidize the mitochondrial pores and result in disruption of the mitochondrial membrane potential, leading to cytochrome c release and subsequently apoptosis (Allen and Tresini, 2000) .
During the preparation of this manuscript, reported that FDXR is induced by p53 and in cells treated with 5-fluorouracil (5-FU) in a p53-dependent manner. They also showed that overexpression of FR suppresses the growth of DLD-1 colorectal carcinoma cells and partial disruption of the FDXR gene decreases the sensitivity of HCT116 colorectal carcinoma cells to 5-FU-induced apoptosis. Here, we confirmed and extended the previous observations. We showed that FDXR is regulated by the p53 family, by DNA damaging agents in a p53-dependent manner, and by a mutated form of p53 that is competent in inducing apoptosis. We identified a p53 response element located within the FDXR promoter that is responsive to various p53 family proteins. We showed that p53, p63a and p73a directly bind to the p53 response element in vivo and promote the accessibility of the FDXR promoter by increasing the acetylation of histones H3 and H4. In addition, we found that over-expression of FR in lung H1299, breast MCF7, and colorectal HCT116 carcinoma cells have no effect on cell proliferation. However, overexpression of FR increases the sensibility of H1299 and HCT116 cells to 5-fluorouracil-, doxorubicin-and H 2 O 2 -mediated apoptosis.
Results

Upregulation of FDXR by p53 family members
In order to identify novel target genes regulated by the p53 family, Affymetrix GeneChip assay was performed. Total RNA was isolated from H1299 cell lines that were uninduced and induced to express p53, p63a, DNp63a, p73a, and p73b, respectively, by withdrawal of tetracycline from the culture medium. cRNA was synthesized and used to hybridize the Affymetrix U95A GeneChip. We found that many known p53 target genes, such as p21, MDM2, and PIG3, were induced by various p53 family members. We also found that some novel genes are potentially regulated by p53 family members. Among these is the ferredoxin reductase gene (FDXR).
To confirm the regulation of FDXR by the p53 family, we performed Northern blot analysis. We found that FDXR was highly induced by p53, p63a, p73a, and p73b but not DNp63a (Figure 1a , upper panel). As a control, we tested expression of p21 and found that p21 was induced by various p53 family proteins ( Figure 1a , middle panel). The level of GAPDH was also determined as a loading control.
We also examined the induction of FDXR by two p53 mutants, that is, p53(R249S) and p53(DAD1DBD). We found that p53(R249S) is incapable of inducing FDXR and p21 (Figure 1b , upper and lower panels).
However, we found that p53(DAD1DBD), which lacks activation domain 1 and the C-terminal basic domain but is still active in inducing apoptosis , strongly induces FDXR (Figure 1b, upper panel) . This suggests that FDXR is a potential mediator of p53(DAD1DBD) in inducing apoptosis.
DNA damage stabilizes and activates p53, leading to induction of p53 target genes (Vogelstein et al., 2000) . If FDXR is a true p53 target, it would be induced by DNA damage in cells that contain an endogenous wildtype p53 gene. To this end, we tested 12 cell lines untreated or treated with camptothecin, which is an inhibitor of topoisomerase 1 and can induce doublestrand DNA breaks (Nelson and Kastan, 1994) . We found that both FDXR and p21 were induced in Figure 1 Up-regulation of FDXR by the p53 family. (a) p53, p63a, p73a, p73b but not DNp63a, induce FDXR. Northern blots were prepared using total RNA isolated from H1299 cells that were uninduced (7) and induced (+) to express various p53 family proteins for 24 h. The blots were probed with cDNAs derived from the FDXR, p21 and GAPDH genes, respectively. (b) FDXR is induced by a deleted form of p53 that is competent in inducing apoptosis, but not by a tumor-derived mutant. The experiment was performed as in (a). (c) FDXR is induced in cells by camptothecin in a p53-dependent manner. The experiment was performed as in (a). (d) FR expression is induced by p53, p63a, p63g, p73a and p73b. Western blots were prepared using cell extracts purified from H1299 cells that were uninduced (7) and induced (+) to express p53, p63a, p63g, p73a or p73b. The HAtagged p53 and p73 were detected with anti-HA and the myctagged p63 was detected with anti-myc. (e) FR expression is induced by DNA damage in HCT116(p53+/+), but not HCT116(p537/7) cells camptothecin-treated HCT116(p53+/+), MCF7, RKO, LNCap, and LS174T ( Figure 1c , upper and lower panels). These cell lines contain wild-type p53. We also found that FDXR was induced by DNA damage in HCT116(p217/7) although it does not express p21 (Figure 1c , upper and lower panels). In contrast, FDXR was not induced in p53-null HCT116(p537/7) cells, p53-null-like MCF7E6 and RKOE6 cells, and SW480 and T98G cells, which contain mutant p53 (Figure 1c, upper panel) . Additionally, we found that FDXR was still induced in HCT116(p53+/7) ( Figure 1c, upper panel) , which has one allele of the wild-type p53 gene.
Next, we determined whether an increase in FDXR transcript levels correlates with an increase in FR protein levels. Exogenous p53, p63a, p63g, p73a and p73b were induced by withdrawal of tetracycline in various H1299 cell lines (Figure 1d ). Endogenous wildtype p53 in HCT116 cells was induced by treatment with camptothecin ( Figure 1e , p53 panel). HCT116 (p537/7) was similarly treated as a negative control ( Figure 1e , p53 panel). We found that the level of FR protein was increased in H1299 cells by exogenous p53, p63a, p63g, p73a and p73b, and in HCT116 cells by endogenous p53 (Figure 1d , e, FR panel). Levels of p21 were determined as a positive control whereas levels of actin determined as an equal loading control ( Figure 1d , e, p21 and actin panels).
Identification of one p53-responsive element within the FDXR promoter
If FDXR is a true target of p53 family, one or more p53 response element should exist in the FDXR gene. To do this, we searched the genomic locus encoding FDXR and found one potential response element (GGGCAgGagCGGGCTTGCCC), which is located 24-nt upstream of the transcription starting site. This sequence contains three mismatches in the non-critical position within the consensus p53-binding site ( Figure 2a ).
To determine whether p53 family members can transactivate gene expression via this element, we performed luciferase assay. A 64-bp DNA fragment containing the response element (from nt 753 to +11) was cloned into a promoter-less luciferase reporter vector pGL2. The resulting vector was designated pGL2-FDXR(753/+11). We also replaced four nucleotides predicted to be critical for p53 binding, that is, the C and G in each half site were replaced with A and T, respectively. The resulting reporter was designated pGL2-FDXR(753/+11)M. Both reporter vectors were co-transfected into H1299 cells with either a pcDNA3 control vector or a vector that expresses various p53 family proteins. We found that the luciferase activity for pGL2-FDXR(753/+11) was markedly increased by p53, p63a, and p73a, but not p53(R175H), DNp63a, and p73a292 . In contrast, the luciferase activity for pGL2-FDXR(753/ +11)M was not increased by all the proteins tested (Figure 2b -d) .
To determine whether these p53 family members can transactivate the potential p53 response element in a more natural condition, we cloned a 1881-bp fragment (from nt 71870 to +11) and a 283-bp fragment (from nt 7272 to +11) from the promoter of the FDXR gene into pGL2 (Figure 2a ). The resulting constructs were designated pGL2-FDXR(71870/+11) and pGL2-FDXR(7272/+11). We found that the luciferase activity for pGL2-FDXR(71870/+11) and pGL2-FDXR(7272/+11) was significantly increased by p53, p63a, and p73a, but not DNp63a, p53(R175H), and p73a(R292H) (Figure 2b -d) .
Next, we investigated whether p63g and p73b, the two short isoforms of p63 and p73, which have a stronger activity in inducing some p53 target genes (Irwin and Kaelin, 2001; Yang et al., 2002) , can regulate the FDXR promoter. We found that the luciferase activity for pGL2-FDXR(753/+11) was more significantly increased by p63g and p73b than by p63a and p73a, respectively (Figure 2e ). To rule out the possibility that the greater transcriptional activity of p63g and p73b is due to a higher level of protein expressed, we measured the level of various p53 family proteins by Western blot analysis. We found that the level of p73a and p73b is similar whereas the level of p63a is even higher than that of p63g (Figure 2f ). In addition, we found that when expressed at a comparable level (Figure 2f ), p53 is more active than p73a and p73b in activating the FDXR promoter (Figure 2e) , consistent with the data obtained from Northern blot analysis ( Figure 1a ). p53 family proteins directly bind to the p53 response element in the FDXR gene in vivo We performed ChIP assay to determine whether p53 family members can directly bind to the p53 response element in vivo. The p53-DNA complexes were immunoprecipitated with either anti-p53 or anti-HA antibody. We found that the captured fragment that contains the p53 response element was dramatically increased upon inducible expression of p53 (Figure 3b , compare lanes 3 and 5 with 2 and 4, respectively), indicating that p53 directly binds to the p53 response element. We also found that both p63a and p73a directly bind to the p53 response element (Figure 3c , compare lanes 3 with 2; Figure 3d , compare lanes 3 and 5 with 2 and 4, respectively). As a negative control, no DNA fragment was enriched by the control antibody Pab419 (Figure 3b -d) .
Hyper-acetylation of histones bound to a promoter is correlated with active transcription (Urnov and Wolffe, 2001) . To determine whether binding of various p53 family members to the p53 response element increases the accessibility of the FDXR promoter, we measured the extent of histone acetylation by ChIP assay. We found that upon induction of p53 and p73a, histones H3 and H4, which bind to the proximal region in the FDXR promoter, were highly acetylated (Figure 3b,d , compare lanes 7 and 9 with 6 and 8, respectively). binding site is responsive to p53, p63a, and p73a, but not to p53(R175H), DNp63a, and p73a(R292H). Each individual reporter vector shown in (a) was co-transfected into H1299 cells with a pcDNA3 control vector, or a vector that expresses various p53 family proteins. The fold increase in relative luciferase activity by various p53 family proteins was calculated using an empty pcDNA3 vector as a control. (e) The relative transcriptional activity of various p53 family members. pGL2-FDXR(753/+11) was co-transfected into H1299 cells with a pcDNA3 control vector, or a vector that expresses various p53 family proteins. The experiment was performed as in (b). (f) Expression level of p53, p73a, p73b, p63a, and p63g. Western blot analysis was performed to quantify the level of various p53 family proteins in H1299 cells transiently transfected with a pcDNA3 vector expressing p53, p73a, p73b, p63a, or p63g. p53, p73a, p73b were detected by anti-HA antibody, and p63a and p63g were detected by anti-myc antibody. The level of actin was detected as a loading control
We also found that upon induction of p63a, H3 acetylation was highly increased whereas H4 acetylation moderately increased (Figure 3c , compare lanes 5 and 7 with 3 and 6, respectively).
Over-expression of FR protein increases the sensitivity of H1299 and HCT116 cells to ROS-induced cell death
To determine whether FR mediates p53 activity, we generated H1299, HCT116, and MCF7 cell lines that express either FR, the N-terminal HA-tagged FR (HA-FR), or the C-terminal HA-tagged FR (FR -HA) under the control of a tetracycline-regulated promoter. One representative H1299 cell line, which expresses HA -FR, FR, or FR -HA, and one representative HCT116 cell line, which expresses FR -HA, were shown in Figure 4a . Note that HA-FR migrated much slower than FR or FR -HA (Figure 4a , lane 2, the slow migrating band), suggesting that the N-terminal HA tag prevents the mitochondrial signal peptide from cleavage.
Next, we performed growth rate analysis and found that FR has no effect on the growth rate of H1299, HCT116, and MCF7 cells (data not shown). In addition, we performed trypan blue staining assays and found that no increased cell death was detected upon FR induction (data not shown). Thus, expression of FR itself has little, if any, effect on these cell proliferations.
One physiological role for FR is to transfer electron from NADPH to cytochrome p450. After NADPH releases an electron, the oxidized NADP receives an electron from ATP to form NADPH. Thus, FR may influence the redox state of the mitochondria and mediate ROS-induced cell death. To test this, we examined whether over-expression of FR increases H 2 O 2 -induced apoptosis. H1299 cells, which were uninduced (7) and induced (+) to express FR-HA, FR, or HA-FR, were treated with 50, 100, 200, or 400 mM H 2 O 2 for 2 h. Surviving cells were counted 2 days after the treatment. We found that the number of surviving cells significantly decreased when FR or FR -HA was expressed (Figure 4b ,c), suggesting that H 2 O 2 -induced apoptosis is enhanced by FR. However, the uncleaved, immature HA -FR was inert ( Figure  4d ), consistent with the previous reports that uncleavable FR is also inactive in the electron transfer (Hanukoglu and Gutfinger, 1989; Kramer et al., 1982) . Similarly, we found that expression of FR-HA increased H 2 O 2 -induced cell death in HCT116 cells (Figure 4e) .
We also performed time course experiments and found that when treated with 50 mM of H 2 O 2 , survived H1299 cells in the absence of FR began to proliferate on day 2 after H 2 O 2 treatment (Figure 4f ). In contrast, FR promoted H 2 O 2 -induced cell death and inhibited cell proliferation (Figure 4f ). When treated with 100, 200, or 400 mM of H 2 O 2 , cells with or without FR expression underwent sustained cell death (Figure 4g -i) . However, at each time point, cell death was increased by FR.
To confirm that the increased cell death induced by H 2 O 2 in the presence of FR expression is due to apoptosis, we performed a DNA histogram analysis. In control cells or cells induced to express FR, less than 2% of cells underwent apoptosis (Figure 4j ,k). When treated with H 2 O 2 , 12.6% of cells underwent apoptosis (Figure 4l ). When both treated with H 2 O 2 and induced to express FR, 30.62% cells underwent apoptosis (Figure 4m ). This is consistent with results obtained from the cell-survival assay (Figure 4b -i) .
Over-expression of FR potentiates 5-FU-and doxorubicin-induced apoptosis
Recently, Hwang et al. (2001) reported that FR is a key mediator of p53-dependent, 5-FU-induced apoptosis in colorectal cancer cells. Since FR alone is not sufficient to induce apoptosis in HCT116 cells, we determined whether FR exerts any effect on 5-FUinduced apoptosis. HCT116 cells, which were uninduced and induced to express FR-HA, were treated with various concentrations of 5-FU for 2 days. We found that like H 2 O 2 -induced cell death, 5-FU- ChIP assay was performed as described in Materials and methods. p53-DNA complexes were captured with antip53 (Pab421 and PAB1801) and anti-HA, respectively. p63a-DNA complexes were captured with anti-myc. p73a-DNA complexes were captured with anti-p73a and anti-HA, respectively. Histone H3-and H4-DNA complexes were captured with antiacetylated H3 and H4 antibodies, respectively. PAb419 antibody was used as a control. The fragment containing the p53 response element was amplified by PCR with primers FDXR-F and FDXR-R induced cell death was substantially increased by FR (Figure 5a ). To further address that FR can potentiate oxidative stress-induced cell death, we treated HCT116 cells, which were uninduced and induced to express FR-HA, with various concentration of doxorubicin, which is a ROS-producing agent in cells (Akman et al., 1992) . We found that like 5-FU-induced cell death, doxorubicin-induced cell death (7) and induced (+) to express FR-HA for 24 h, were treated by 50, 100 and 200 mM of H 2 O 2 , respectively. The experiment was performed as in (b). (f -i) H1299 cells, which were uninduced (7) or induced (+) to express FR-HA for 24 h, were treated for 2 h with 50, 100, 200, and 400 mM of H 2 O 2 , respectively. The percentage of surviving cells over 5-day period was determined. (j -m) H1299 cells, which were uninduced (j), induced to express FR (k), treated with 400 mM H 2 O 2 for 2 h (l), or treated with 400 mM H 2 O 2 for 2 h and induced to express FR (m), were stained with propidium iodide for DNA histogram analysis was increased by FR expression (Figure 5b ). To confirm that the increased cell death induced by 5-FU and H 2 O 2 in the presence of FR expression is due to apoptosis, we performed a DNA histogram analysis. In control HCT116 cells or cells induced to express FR, less than 1% of cells underwent apoptosis (Figure 5c,d ). When treated with 40 mg/ml 5-FU (Figure 5e ) and 100 mM H 2 O 2 (Figure 5g ), 10.04% and 11.08% of cells underwent apoptosis, respectively. However, when both induced to express FR and treated with 5-FU or H 2 O 2 , nearly 50% and 42% of cells underwent apoptosis, respectively (Figure 4f,g ). Again, these data are consistent with results obtained from the cell-survival assay (Figures  5a and 4e) .
Discussion
We have demonstrated that FDXR is a target gene of the p53 family, that is, p53, p63a, p63g, p73a, and p73b. DNp63a is incapable of inducing FDXR. This is consistent with our previous report that various p63 isoforms differentially regulate p53 family target genes (Dohn, 2001a) . We have also shown that induction of FDXR correlates with p53 activation in cells carrying an endogenous wild-type p53 gene when treated with DNA damaging agent. Furthermore, we have found that FDXR can be upregulated by a p53 mutant that is competent in inducing apoptosis, but not tumor-derived p53 mutant that is defective in transactivation, suggesting Figure 5 Over-expression of FR increases the sensitivity of HCT116 cells to 5-FU-and Doxorubicin-induced apoptosis. (a) HCT116 cells, which were uninduced (7) or induced (+) to express FR-HA for 24 h, were treated with 5, 10, 15, 20, and 40 mg/ml 5-FU, respectively. The percentage of surviving cells on day 2 was determined. (b) HCT116 cells, which were uninduced (7) or induced (+) to express FR-HA for 24 h, were treated with 0.125, 0.25, 0.5, 1.0, and 2.0 mg/ml doxorubicin, respectively. The percentage of surviving cells on day 2 was determined. (c -h) HCT116 cells, which were uninduced (c), induced to express FR-HA (d), treated with 40 mg/ml 5-FU (e), treated with 40 mg/ml 5-FU and induced to express FR-HA (f), treated with 100 mM H 2 O 2 for 2 h (g), or treated with 100 mM H 2 O 2 for 2 h and induced to express FR-HA (h), were stained with propidium iodide for DNA histogram analysis that FDXR is a potential mediator of p53-dependent apoptosis.
We have found a p53 response element within the promoter of FDXR. We showed that the p53 response element is responsive to various p53 family proteins. When the critical nucleotides are mutated, the mutant p53 response element is inert. We found that the short isoforms p63g and p73b are more potent in activating the p53 response element within the promoter of FDXR than p63a and p73a, which contain the SAM domain in their C-terminus. In addition, we demonstrated by ChIP assay that p53, p63a, and p73a directly bind to the p53 response element in vivo and the binding of these p53 family proteins promotes the accessibility of the FDXR promoter for transcription by increasing histone acetylation. These data strongly suggest that FDXR is a bona fide target gene of the p53 family.
We showed that over-expression of FR sensitizes HCT116 cells to H 2 O 2 -, 5-FU-and doxorubicin-induced cell death, consistent with the recent report by Vogelstein's group that somatic deletion of two of the three FDXR alleles renders HCT116 cells less sensitive to 5-FU-induced apoptosis . Nevertheless, over-expression of FR in HCT116, H1299, and MCF7 cells is not sufficient for inducing apoptosis, which is different from the previous report that overexpression of FR inhibited cell proliferation of DLD-1 cells . This is probably due to different cell lines used. Another possibility is levels of FR protein expressed. In this study, we have generated and used cell lines that express FR protein to a level comparable to that of endogenous FR protein induced by various p53 family proteins (data not shown).
FR, a 50-kD mitochondrial flavoprotein, participates in the cleavage of cholesterol side chain to form pregnenolone, cortisol, and aldosterone in a multi-step biosynthesis, which generates molecular oxygen by reductive splitting of dioxygen and requires the transfer of electrons by FR via ferredoxin to cytochrome P450 (Muller et al., 2001) . Here, we and Hwang et al. (2001) have found that in addition to the biosynthesis of steroid hormones, FR sensitizes cancer cells to ROSinduced apoptosis.
Several mechanisms by which ROS induce apoptosis have been proposed (Chandra et al., 2000) : (i) ROS act on mitochondria, causing a disruption of the mitochondria membrane potential and subsequently the release of cytochrome c; (ii) ROS upregulate the expression of Fas and FasL; and (iii) ROS modify the activity of transcription factors involved in the cell death and survival pathways. How does FR regulate ROS-induced apoptosis, especially by H 2 O 2 , 5-FU and doxorubicin? It seems unlikely that FR increases the production of ROS because over-expression of FR does not show increased apoptosis. It is plausible that FR may hinder ROS from being detoxified by antioxidant system. We hypothesize that in response to various stress conditions, FR is accumulated in mitochondria, which increases the electron transfer process and subsequently depletes the available pool of reduced NADPH. Since antioxidant system needs reduced NADPH to detoxify ROS, lack of such an electron donor would amply ROS-induced apoptosis.
Taken together, our data support the model of feed forward loop proposed by Hwang et al. (2001) for p53 function, that is, p53 is activated and induces apoptosis in response to various cellular stresses at least in part through ROS, and simultaneously p53 also increases expression of FR, which in turn enhances p53 function by increasing ROS-induced apoptosis. It should be noted that as a target of p53, FR can sensitize ROS-induced apoptosis in a p53-independent manner.
Materials and methods
Cell culture
H1299, HCT116, LS174T, LNCap, and MCF7 were supplied by American Type Culture Collection. HCT116 (p537/7), HCT116(p53+/7) and HCT116(p217/7) are derivatives of HCT116 (Bunz et al., 1998; Waldman et al., 1995) . RKO, SW480, and T98G were cultured as described previously (Nelson and Kastan, 1994) . MCF7E6 and RKOE6 are functionally p53-null and derived from MCF7 and RKO, respectively (Munger et al., 1989) . H1299 cell lines that inducibly express various p53 family proteins were cultured as described previously (Chen et al., 1996a; Dohn, 2001b; Zhu et al., 1998a; Zhu et al., 1999) . H1299, MCF7, and HCT116 cell lines that inducibly express FR were generated as described previously (Chen et al., 1996b) .
Plasmids
FDXR cDNA was generated by RT -PCR using total RNA purified from H1299 cells with forward primer 5' -AAC CAC CAT GGC TTC GCG CTG CTG GCG C-3' and reverse primer 5' -GCG AAT TCG GGC TGG GCT CAG TG-3'. To generate HA-FDXR cDNA that contains an HA epitope sequence at 5' end, FDXR was amplified with forward primer 5' -AAC CAC CAT GGG CTA CCC ATA CGA TGT TCC AGA TTA CGC TGC ATC ACG TTG CTG GCG CTG -3' and reverse primer 5'-GCG AAT TCG GGC TGG GCT CAG TG-3'. To generate FDXR-HA cDNA that contains an HA epitope sequence at 3' end, FDXR was amplified with forward primer 5'-AAC CAC CAT GGC TTC GCG CTG CTG GCG C-3' and reverse primer 5'-TCA AGC GTA ATC TGG AAC ATC GTA TGG GTA GTG GCC CAG GAG GCG CAG CAT-3'. The sequence identify for HA-FDXR, FDXR, and FDXR-HA was confirmed by DNA sequencing. These cDNAs were cloned into a tetracycline-repressible expression vector and the resulting plasmids were used to generate inducible cell lines.
Affymetrix GeneChip assay and Northern blot analysis
Total RNA was isolated from cells using Trizol reagent (Invitrogen, CA). U95A GeneChip was purchased from Affymetrix, which contains cDNA representing 12 000 unique human genes. GeneChip analysis was performed according to the manufacturer's instruction. Northern blot analysis was performed as described previously (Chen et al., 1995; Zhu et al., 1999) . p21 and GAPDH probes were prepared as described previously (Zhu et al., 1998b) . The FDXR probe was prepared from an EST clone (GenBank #AA 613998).
Western blot analysis
Western blot analysis was performed as described previously (Chen et al., 1996a) . Rabbit anti-FR antibody was a generous gift of Bert Vogelstein . Antibodies against p53, p21, HA and myc epitopes, and actin were described previously (Dohn et al., 2001a,b) .
Luciferase assay
An 1881-base pair fragment from the FDXR promoter (from nt 71870 to +11) was amplified from the genome DNA purified from H1299 cells with forward primer 5'-CTC GAG TGT AAA GGA CCA GAT AGT-3' and reverse primer 5'-AAG CTT TGC AAG TGG ATC TGT TCC TAG-3'. The fragment was cloned into a promoter-less luciferase reporter vector pGL2 (Promega, Madison, WI, USA) and the resulting plasmid is designated pGL2-FDXR(71870/+11). pGL2-FDXR(7272/+11) and pGL2-FDXR(753/+11) were derived from pGL2-FDXR(71870/+11). pGL2-FDXR(753/+11)M was generated with a mutated p53 response element. 1.0 mg of pcDNA3 or a vector expressing various p53 family proteins, was co-transfected into H1299 cells with 2.0 mg of a reporter vector. Dual luciferase assays were performed in triplicate according to the manufacturer's instruction (Promega).
Chromatin immunoprecipitation assay (ChIP)
ChiP assay was performed essentially as described (Chen et al., 1999; Szak et al., 2001) . 5610 7 H1299 cells, that were uninduced (7) and induced (+) to expression p53, p63a and p73a, were cross-linked by 1% formaldehyde for 10 min at room temperature. Cell extracts were prepared and sonicated to generate 200-to 1000-bp DNA fragments. Protein-DNA complexes were immunoprecipitated with various antibodies. The DNA-protein cross-links were reversed by heating at 658C for 4 h. After removal of protein by phenol and chloroform extraction, DNA was purified by ethanol precipitation. To amplify the region from nt 7164 to+40 in the FDXR promoter, PCR was performed with forward primer FDXR-F (5'-GGG CGG GTC TCT CTT TTG GG-3') and reverse primer FDXR-R (5'-GCG CGA AGC CAT GGC TGG GAG CAG-3').
Cytotoxicity induced by H 2 O 2 , 5-FU and doxorubicin
1610
5 cells, which were uninduced (7) or induced (+) to express FR, were plated in a 6-cm dish. After 1 day culturing, both uninduced and induced cells were treated with various concentrations of H 2 O 2 for 2 h, and then rinsed with and cultured in fresh medium. For 5-FU or doxorubicin treatment, 1.5610 5 HCT116 cells, which were uninduced (7) or induced (+) to express FR, were plated in a 6-cm dish. After 1 day induction, both uninduced and induced cells were treated with various concentrations of 5-FU or doxorubicin for 2 days. For cell counting, each plate was washed with PBS and live cells on the plate were counted three times. The percentage of live cells on day 0 was set as 100%. The percentage of live cells after various days of treatment was the product of total live cells divided by total number of cells on day 0.
DNA histogram analysis
Both floating dead cells in the medium and live cells on the plate were collected and fixed with 2 ml of 100% ethanol for at least 30 min. FACS analysis was performed as described previously (Chen et al., 1996b) . The percentage of cells in the Sub-G1 phase was determined using the CELLQuest program.
